SMi proudly present their 2nd annual conference on Allergies, taking place on 8th & 9th July 2015 in London, UK. Allergies 2015 will focus on developments of novel vaccines and adjuvants for immunotherapy, along with a strong focus on allergy clinical trials and pharmacovigilance to gain a solid understanding of the current requirements and obligations in the development of immunotherapy products.The conference will highlight increasing patient compliance and increasing quality of life for patients that are being treated on a day to day basis through new mechanisms of delivery. There is also a emphasis on personalised medicines for the treatment of specific phenotypes rather than taking the one fits all strategy and new pathways for pioneering targeting strategies to be developed.5 Reasons Why You Should Attend:Discovering novel strategies being implemented in the field of vaccines and adjuvants for immunotherapyOvercoming challenges faced in the development of clinical trials for allergen therapeutics including trial policies and paediatricsCreating new solutions for the delivery of therapeutics to increase patient quality of life and increase compliance to provide an optimal treatment strategyHighlighting new pathways involved in the development of allergy to provide a better understanding of new targets for drug development and targetingReviewing new developments in the field of allergy immunotherapeutics to provide an insight into future development prospects.Key Speakers Include:Tim Higenbottam, Research & Development Director, Allergy TherapeuticsRod Hafner, Senior Vice President R&D, CircassiaDiderik Boot, Medical Director, HAL AllergiesPierre-Henri Benhamou, CEO, DBV TechnologiesJuan Gispert, Senior Medical Director, European Head Allergy, Respiratory, Infectious Diseases and Vaccines, QuintilesTracy Hussell, Principal Investigator, University of Manchester, HaemostatixHow to Register:Contact Andrew Gibbons on +44 (0) 20 7827 6156